CMG Pharmaceutical Co Ltd
KOSDAQ:058820
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
C
|
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
|
304.6B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
287.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
98.9B EUR |
Loading...
|
Market Distribution
| Min | -168 471.3% |
| 30th Percentile | -2.9% |
| Median | 1.9% |
| 70th Percentile | 5.8% |
| Max | 21 012.5% |
Other Profitability Ratios
CMG Pharmaceutical Co Ltd
Glance View
CMG Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical drugs. The company is headquartered in Seoul, Seoul and currently employs 243 full-time employees. The company went IPO on 2001-08-31. The Company’s products include antibiotics, antifungals, antivirus, anti-tuberculousis drugs, peptic ulcer drugs, dementia remedies, antihistamines and antipyretics, among others. The company is also engaged in the manufacture of stone products. The firm mainly distributes is pharmaceutical products within domestic markets, as well as to overseas markets. On April 16, 2013, the Company changed its name from SKYNEWPHARM. Co., Ltd to CMG Pharmaceutical Co., Ltd.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for CMG Pharmaceutical Co Ltd is -9.6%, which is below its 3-year median of 1%.
Over the last 3 years, CMG Pharmaceutical Co Ltd’s Net Margin has decreased from 6.2% to -9.6%. During this period, it reached a low of -19% on Jun 30, 2025 and a high of 8.9% on Jun 30, 2024.
